Our cross-sectional study showed that the interaction between apolipoprotein E4 (ApoE4) and angiotensin converting enzyme (ACE) inhibitors was associated with Alzheimer’s disease (AD). The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.